Patents by Inventor Lise-Marie Fueg

Lise-Marie Fueg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicinal aerosol formulations
    Patent number: 10471077
    Abstract: The present invention provides a medical aerosol suspension formulation of MDI administration, comprising: a) micronized pa-agonist; b) micronized corticosteroid; c) a sib-therapextric quantity of a moisture-scavenger excipient; and d) a HFA propellant; wherein (a), (b), and (c) and their respective relative amounts are selected such that they associate to form floccules having a density substantially the same as that of the HFA propellant.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: November 12, 2019
    Assignee: Jagotec AG
    Inventors: Rudi Mueller-Walz, Lise-Marie Fueg
  • Formulations
    Publication number: 20180296468
    Abstract: In a metered dose inhaler, comprising a canister and metering valve, containing a suspension aerosol formulation comprising particles of formoterol fumarate dihydrate and fluticasone propionate suspended in an HFA propellant, a method of reducing deposition of particles on the surfaces of the canister and the metering valve, the method comprising the step of adding a wetting agent to the formulation.
    Type: Application
    Filed: March 21, 2017
    Publication date: October 18, 2018
    Applicant: Jagotec AG
    Inventors: Rudi Mueller-Walz, Lise-Marie Fueg
  • Formulations
    Publication number: 20170281529
    Abstract: In a metered dose inhaler, comprising a canister and metering valve, containing a suspension aerosol formulation comprising particles of formoterol fumarate dihydrate and fluticasone propionate suspended in an HFA propellant, a method of reducing deposition of particles on the surfaces of the canister and the metering valve, the method comprising the step of adding a wetting agent to the formulation.
    Type: Application
    Filed: March 21, 2017
    Publication date: October 5, 2017
    Inventors: Rudi Mueller-Walz, Lise-Marie Fueg
  • Medicinal Aerosol Formulations
    Publication number: 20170189423
    Abstract: The present invention provides a medical aerosol suspension formulation of MDI administration, comprising: a) micronized pa-agonist; b) micronized corticosteroid; c) a sib-therapextric quantity of a moisture-scavenger excipient; and d) a HFA propellant; wherein (a), (b), and (c) and their respective relative amounts are selected such that they associate to form floccules having a density substantially the same as that of the HFA propellant.
    Type: Application
    Filed: September 14, 2016
    Publication date: July 6, 2017
    Inventors: Rudi Mueller-Walz, Lise-Marie Fueg
  • MEDICINAL AEROSOL FORMULATIONS
    Publication number: 20140314684
    Abstract: The present invention provides a process for making a stabilized medical aerosol suspension formulation for administration by a pressurized metered dose inhaler.
    Type: Application
    Filed: May 16, 2014
    Publication date: October 23, 2014
    Applicant: JAGOTEC AG
    Inventors: Rudi Mueller-Walz, Lise-Marie Fueg
  • Improved Medicinal Aerosol Formulations
    Publication number: 20120282189
    Abstract: The present invention provides a medicinal aerosol suspension formulation for MDI administration, comprising: a) micronised pa-agonist; b) micronised corticosteroid; c) a siib-therapexrtic quantity of a moisture-scavenger excipient; and d) a HFA propellant; wherein (a), (b) and (c) and their respective relative amounts are selected such that they associate to form floccules having a density substantially the same as that of the HFA propellant.
    Type: Application
    Filed: October 15, 2010
    Publication date: November 8, 2012
    Applicant: Jagotec AG
    Inventors: Rudi Mueller-Walz, Lise-Marie Fueg
  • Formulations
    Publication number: 20120263766
    Abstract: In a metered dose inhaler, comprising a canister and metering valve, containing a suspension aerosol formulation comprising particles of formoterol fumarate dihydrate and fluticasone propionate suspended in an HFA propellant, a method of reducing deposition of particles on the surfaces of the canister and the metering valve, the method comprising the step of adding a wetting agent to the formulation.
    Type: Application
    Filed: October 15, 2010
    Publication date: October 18, 2012
    Inventors: Rudi Mueller-Walz, Lise-Marie Fueg